Iron Deficiency Anemia Treatments
IRON DEFICIENCY ANEMIA TREATMENTS | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iron deficiency accounts for approximately one-half of anemia cases. Causes of iron deficiency anemia (IDA) can include inadequate iron intake, decreased iron absorption, increased iron demand, and increased iron loss. Treatment can be initiated with oral iron therapy to replenish iron stores. For patients unable to tolerate or absorb oral preparations, parenteral therapy may be used. |
|||||||||||||||||||||||
Iron deficiency anemia diagnosed | |||||||||||||||||||||||
▼ | |||||||||||||||||||||||
• Treat underlying cause • Initiate oral iron therapy |
Not tolerated |
► | Start intravenous iron therapy1 |
||||||||||||||||||||
▼ | |||||||||||||||||||||||
Improved hematocrit and RBC indices?2 |
|||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||
▼ | |||||||||||||||||||||||
Continue oral iron for 3mos after hematocrit/ferritin normalize, then discontinue |
|||||||||||||||||||||||
▼ | |||||||||||||||||||||||
Normal values after |
|||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||
▼ | ▼ | ▼ | |||||||||||||||||||||
No further monitoring unless symptomatic |
• Reevaluate for underlying cause • Consider intravenous iron • Transfuse if symptomatic3 |
||||||||||||||||||||||
IRON THERAPY | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Generic | Brand | Strength | Form | Elemental iron | Dose | ||||||||||||||||||
ORAL | |||||||||||||||||||||||
carbonyl iron |
OTC |
45mg |
caplets |
45mg |
Adults: 1 caplet once daily. |
||||||||||||||||||
carbonyl iron + ferrous gluconate |
Ferralet 904,5,8 |
Rx |
90mg |
tabs |
90mg |
Adult: Take 2hrs after meals. 1 tab once daily. |
|||||||||||||||||
ferrous asparto glycinate (Sumalate) |
Feriva 21/74,13 |
Rx |
75mg |
tabs |
75mg |
Adults: 1 tab once daily for 28 days; repeat as needed. |
|||||||||||||||||
ferrous asparto glycinate (Sumalate) + ferrous bisglycinate chelate (Ferrochel) + ferrous fumarate |
Feriva FA4,10,14 |
Rx |
110mg |
gel caps |
110mg |
Adults: 1 cap once daily. |
|||||||||||||||||
ferrous fumarate |
OTC |
325mg |
tabs |
106mg |
Adults: 1 tab once daily. |
||||||||||||||||||
OTC |
160mg |
timed-rel caplets |
50mg |
Adults: 1 caplet once daily or as needed. |
|||||||||||||||||||
ferrous gluconate |
— |
OTC |
324mg |
tabs |
38mg |
Adults: 1 tab 3–4 times daily. |
|||||||||||||||||
OTC |
240mg |
tabs |
27mg |
Adults: 1 tab once daily. |
|||||||||||||||||||
ferrous sulfate |
— |
OTC |
325mg |
tabs |
65mg |
Adults: May mix elixir with water or fruit juice. 1 tab or 5mL once daily. |
|||||||||||||||||
220mg/5mL |
44mg/5mL |
||||||||||||||||||||||
OTC |
325mg |
tabs |
65mg |
||||||||||||||||||||
Fer-In-Sol6,9 |
OTC |
75mg/mL |
drops |
15mg/mL |
Adults: Not recommended. |
||||||||||||||||||
OTC |
142mg |
sust-rel tabs |
45mg |
Adults: 1 tab once daily. |
|||||||||||||||||||
polysaccharide iron complex + heme iron polypeptide (as Proferrin) |
OTC |
22mg + 6mg |
caplets |
28mg |
Adults: 1 caplet once daily. |
||||||||||||||||||
INJECTABLE | |||||||||||||||||||||||
ferric carboxymaltose |
Rx |
750mg/15mL |
soln for IV push or infusion |
50mg/mL |
Adults: Give by slow IV push (undiluted) at rate of approx. 100mg/min; or by IV infusion (diluted) over ≥15mins. Give in 2 doses separated by ≥7 days. <50kg: 15mg/kg/dose. ≥50kg: 750mg/dose. Total cumulative dose per course: max 1500mg. May repeat treatment if condition reoccurs. |
||||||||||||||||||
ferumoxytol |
Feraheme11 |
Rx |
510mg/17mL |
soln for IV infusion |
30mg/mL |
Adults: Infuse over ≥15mins. Initially 510mg, followed by a second 510mg 3–8 days later. May repeat treatment if condition persists or reoccurs. |
|||||||||||||||||
iron dextran7 |
Rx |
100mg/2mL |
soln for IV or IM inj |
50mg/mL |
Adults and Children: <4mos: Not recommended. Give 0.5mL test dose first; if no anaphylactic-type reactions, may give full therapeutic dose. ≥4mos: IDA: determine total dose based on hemoglobin and body weight (see full labeling). Iron replacement for blood loss: Replacement iron (mg) = blood loss (mL) x hematocrit. Max daily doses: <5kg: 0.5mL (25mg), <10kg: 1mL (50mg), ≥10kg: 2mL (100mg). |
||||||||||||||||||
iron sucrose |
Venofer |
Rx |
20mg/mL |
soln for IV push or infusion |
20mg/mL |
Adults: Give by slow IV push (undiluted) or infusion (diluted). Usual total cumulative dose: 1000mg. HDD: 100mg slow IV push over 2–5mins or infuse 100mg over ≥15mins per consecutive session. NDD: 200mg slow IV push over 2–5mins or infuse 200mg over ≥15mins on 5 different occasions within a 14-day period. PDD: two infusions of 300mg over 1.5hrs 14 days apart, then one 400mg infusion over 2.5hrs 14 days later. |
|||||||||||||||||
sodium ferric gluconate complex in sucrose |
Rx |
62.5mg/5mL |
soln for IV push or infusion |
12.5mg/mL |
Adults: Give by IV infusion (diluted) or slow IV push (undiluted). 125mg infused over 1hr or by slow IV push (up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose. |
||||||||||||||||||
NOTES | |||||||||||||||||||||||
Key: CBC=complete blood count; HDD=hemodialysis dependent; IDA=iron deficiency anemia; NDD=non-dialysis dependent; PDD=peritoneal dialysis dependent; RBC=red blood cell 1 Indications for intravenous iron include intolerable GI effects, worsening symptoms of inflammatory bowel disease, unresolved bleeding, renal failure–induced anemia treated with erythropoietin, and insufficient absorption (eg, celiac disease, gastrectomy, gastrojejunostomy, bariatric surgery, or other small bowel surgeries). 2 Perform monthly CBC 3 Tranfuse with 2 units packed RBCs, then perform clinical assessment to guide further treatment. Transfusion is recommended in pregnant women with hemoglobin <6g/dL. 4 Contains Vit.C, Vit.B12, folic acid 5 Contains docusate sodium 6 Gluten-free 7 Higher incidence of life-threatening anaphylaxis 8 Contains tartrazine 9 Contains sulfites, alcohol 10 Contains biotin 11 Contains mannitol 12 Contains benzyl alcohol 13 Contains zinc, succinic acid, inert tabs 14 Contains copper Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling. |
|||||||||||||||||||||||
REFERENCE | |||||||||||||||||||||||
Short MW, Domagalski JE. Iron Deficiency Anemia: Evaluation and Management. Am Fam Physician. 2013;87(2):98-104. (Created 7/2019) |